Incyte
INCY
#1218
Rank
โ‚ฌ16.11 B
Marketcap
80,96ย โ‚ฌ
Share price
0.50%
Change (1 day)
42.06%
Change (1 year)

Revenue for Incyte (INCY)

Revenue in 2024: โ‚ฌ4.07 Billion

According to Incyte's latest financial reports the company's current revenue (TTM ) is โ‚ฌ4.18 Billion. In 2024 the company made a revenue of โ‚ฌ4.07 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ3.34 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Incyte from 1996 to 2024

Annual revenue

Year Revenue Change
2024โ‚ฌ4.07 B21.91%
2023โ‚ฌ3.34 B5.64%
2022โ‚ฌ3.16 B20.02%
2021โ‚ฌ2.63 B21.62%
2020โ‚ฌ2.16 B12.51%
2019โ‚ฌ1.92 B17.15%
2018โ‚ฌ1.64 B28.48%
2017โ‚ฌ1.28 B21.8%
2016โ‚ฌ1.05 B52.49%
2015โ‚ฌ0.68 B63.91%
2014โ‚ฌ0.42 B63.63%
2013โ‚ฌ0.25 B14.45%
2012โ‚ฌ0.22 B208.76%
2011โ‚ฌ72.73 M-43.05%
2010โ‚ฌ0.12 B1874.94%
2009โ‚ฌ6.46 M130.63%
2008โ‚ฌ2.8 M-88.11%
2007โ‚ฌ23.58 M12.59%
2006โ‚ฌ20.95 M216.27%
2005โ‚ฌ6.62 M-16.56%
2004โ‚ฌ7.93 M-78.78%
2003โ‚ฌ37.4 M-61.52%
2002โ‚ฌ97.2 M-60.85%
2001โ‚ฌ0.24 B20.46%
2000โ‚ฌ0.20 B32.07%
1999โ‚ฌ0.15 B37.39%
1998โ‚ฌ0.11 B51.12%
1997โ‚ฌ75.16 M117.03%
1996โ‚ฌ34.63 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚ฌ49.33 B 1,077.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ54.65 B 1,204.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.72 B 1,134.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ31.31 B 647.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.21 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
โ‚ฌ0.15 B-96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚ฌ65.95 M-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚ฌ82.1 M-98.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚ฌ0.34 B-91.73%๐Ÿ‡บ๐Ÿ‡ธ USA